Our finding that hypoxic monocytes produce elevated chemokine ISG levels upon SARS-CoV-2 infection in a TLR4- and cholesterol-dependent manner might open new therapeutic opportunities to prevent systemic progression of severe COVID-19 cases. The gene discussed is TLR4; the disease is COVID-19.